conv.

All stories
TechQuiet 12d · day 12

NeuroXess raises $105M for brain implant clinical trials and manufacturing

Chinese BCI developer enters registration trial across 15 hospitals as investors back clinical validation over proof-of-concept.

newest coverage 11d agosummary written 10d ago2 pieces Newswires

What to know

  • NeuroXess raised $105M in Series B funding to advance clinical trials, regulatory approval, and manufacturing of a fully implanted, wireless BCI system that handles motion decoding, speech decoding, and environmental control.
  • The device entered a registration clinical trial in July 2026 across 15 Class III hospitals and joined China's NMPA innovative device review program, signaling progress toward Class III market approval.
  • The round reflects a shift in Chinese investor appetite from BCI as speculative sci-fi to backing companies pursuing clinical delivery, with the sector designated a national 'future industry' targeting 2030 commercialization.
  • Safety and functional benefit remain to be established; founder Tao Hu estimates hundreds or thousands of clinical cases are needed before a generalisable algorithm can be built.
most voices

This represents genuine progress in a maturing BCI sector backed by serious capital and regulatory milestones.

  • “Chinese BCI companies are now scrambled for investment quota, a shift from when the field was a relatively immature sci-fi concept.”

    Tao Hu · Dealroom.co ↗

“Full implantation keeps all components, including the battery, inside the body; wireless power and data transfer let patients shower, sleep, and socialise unaffected”

NeuroXess, BCI developer · Dealroom.co ↗

NeuroXess Chinese BCI startupTao Hu Founder and chief scientistSDIC Juli, Shenzhen Venture Capital Group, Qinzhi Capital Series B lead investors

NeuroXess raises $105M for brain implant clinical trials and manufacturing
runtimewire.com

How it unfolded 1 development · click the chart to see its coverage articles

Peak 2 pieces in 3h at Nov 1, 1 AM; 2 pieces over 12 days (2 articles) Nov 1, 1 AM — 2 pieces · 2 articles — Newswires 2Nov 1, 3 AM — quietNov 1, 6 AM — quietNov 1, 9 AM — quietNov 1, 12 PM — quietNov 1, 3 PM — quietNov 1, 6 PM — quietNov 1, 9 PM — quietNov 2, 12 AM — quietNov 2, 3 AM — quietNov 2, 6 AM — quietNov 2, 9 AM — quietNov 2, 12 PM — quietNov 2, 3 PM — quietNov 2, 6 PM — quietNov 2, 9 PM — quietNov 3, 12 AM — quietNov 3, 3 AM — quietNov 3, 6 AM — quietNov 3, 9 AM — quietNov 3, 12 PM — quietNov 3, 3 PM — quietNov 3, 6 PM — quietNov 3, 9 PM — quietNov 4, 12 AM — quietNov 4, 3 AM — quietNov 4, 6 AM — quietNov 4, 9 AM — quietNov 4, 12 PM — quietNov 4, 3 PM — quietNov 4, 6 PM — quietNov 4, 9 PM — quietNov 5, 12 AM — quietNov 5, 3 AM — quietNov 5, 6 AM — quietNov 5, 9 AM — quietNov 5, 12 PM — quietNov 5, 3 PM — quietNov 5, 6 PM — quietNov 5, 9 PM — quietNov 6, 12 AM — quietNov 6, 3 AM — quietNov 6, 6 AM — quietNov 6, 9 AM — quietNov 6, 12 PM — quietNov 6, 3 PM — quietNov 6, 6 PM — quietNov 6, 9 PM — quietNov 7, 12 AM — quietNov 7, 3 AM — quietNov 7, 6 AM — quietNov 7, 9 AM — quietNov 7, 12 PM — quietNov 7, 3 PM — quietNov 7, 6 PM — quietNov 7, 9 PM — quietNov 8, 12 AM — quietNov 8, 3 AM — quietNov 8, 6 AM — quietNov 8, 9 AM — quietNov 8, 12 PM — quietNov 8, 3 PM — quietNov 8, 6 PM — quietNov 8, 9 PM — quietNov 9, 12 AM — quietNov 9, 3 AM — quietNov 9, 6 AM — quietNov 9, 9 AM — quietNov 9, 12 PM — quietNov 9, 3 PM — quietNov 9, 6 PM — quietNov 9, 9 PM — quietNov 10, 12 AM — quietNov 10, 3 AM — quietNov 10, 6 AM — quietNov 10, 9 AM — quietNov 10, 12 PM — quietNov 10, 3 PM — quietNov 10, 6 PM — quietNov 10, 9 PM — quietYesterday, 12 AM — quietYesterday, 3 AM — quietYesterday, 6 AM — quietYesterday, 9 AM — quietYesterday, 12 PM — quietYesterday, 3 PM — quietYesterday, 6 PM — quietYesterday, 9 PM — quietToday, 12 AM — quietToday, 3 AM — quietToday, 6 AM — quietToday, 9 AM — quietToday, 12 PM — quietToday, 3 PM — quietToday, 6 PM — quiet 1
Nov 2Nov 3Nov 4Nov 5Nov 6Nov 7Nov 8Nov 9Nov 10yesterdaynow · 9:09 PM ET
  1. 1

    NeuroXess plans 14,300-square-meter factory targeting 10,000 units of capacity

    Founder Tao Hu is pairing the multicenter registration trial with plans for manufacturing infrastructure, tying production plans to the outcome of the registration process.

    “fully implanted, fully wireless, fully functional…”
    — NeuroXess, BCI developer · source
    1. 1 outlet NeuroXess raises 700 million yuan to fund brain implant trials and production

      first by RuntimeWire, 11d ago

      1 more headline
  2. background

    NeuroXess joins NMPA innovative device review program — The system joined the National Medical Products Administration's innovative device review program, a step toward the data required for Class III registration.

  3. background

    NeuroXess raises $105 million Series B for clinical validation and manufacturing — Chinese brain-computer interface developer NeuroXess raised $96.3 million (roughly $105 million) in a Series B round led by SDIC Juli, Shenzhen Venture Capital Group, and Qinzhi Capital, with backing from SMIC Puhua, IDG Capital, and others. The funding will support multi-centre clinical trials, registration, mass-production construction, next-generation R&D, and integration of BCI with AI.

  4. background

    NeuroXess enters registration clinical trial at Huashan Hospital — The registration clinical trial began on July 7, 2026, at Huashan Hospital, Fudan University, running across 15 Class III hospitals nationwide.

What people are saying 0 voices from 0 sites · verbatim